Literature DB >> 16806627

Estimation of ochratoxin A in portuguese population: new data on the occurrence in human urine by high performance liquid chromatography with fluorescence detection.

A Pena1, M Seifrtová, C Lino, I Silveira, P Solich.   

Abstract

With increasing knowledge of the persistence of OTA in the food chain, exposure to this mycotoxin is a potential human health hazard to humans, and evaluating its presence in populations has become highly important. A sensitive and accurate analytical method for the determination of ochratoxin A in urine was validated, since is less invasive than blood monitoring. It involves extraction with 5% NaHCO3, immunoaffinity column (IAC) for clean-up and high performance liquid chromatography with fluorescence detection (HPLC-FD). The limit of quantification was 0.02 ng/mL of urine (1.3 ng/mL of the extract injected) and recovery of ochratoxin A from urine samples spiked at the three fortification levels, were higher than 90% with RSD lower than 9%. The identification of OTA was confirmed by methyl ester derivatization and then HPLC analysis. Based in ours first results we can assume that OTA conjugation with glucuronic acid in human urine occurs. In the present study, we follow up OTA levels in 60 urine samples of inhabitants from Coimbra city, Portugal, in order to evaluate population contamination, and the presence of OTA was found in 42 samples, at concentrations above the LOQ, ranged between 0.021 and 0.105 ng/mL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806627     DOI: 10.1016/j.fct.2006.04.017

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  14 in total

1.  Enniatin B and ochratoxin A in the blood serum of workers from the waste management setting.

Authors:  Susana Viegas; Bernd Osteresch; Ana Almeida; Benedikt Cramer; Hans-Ulrich Humpf; Carla Viegas
Journal:  Mycotoxin Res       Date:  2017-11-29       Impact factor: 3.833

2.  Evidence of ochratoxin A conjugates in urine samples from infants and adults.

Authors:  K Muñoz; B Cramer; J Dopstadt; H-U Humpf; G H Degen
Journal:  Mycotoxin Res       Date:  2016-11-09       Impact factor: 3.833

3.  Exposure of neonates to ochratoxin A: first biomonitoring results in human milk (colostrum) from Chile.

Authors:  Katherine Muñoz; Victor Campos; Meinolf Blaszkewicz; Mario Vega; Alejandro Alvarez; Jorge Neira; Gisela H Degen
Journal:  Mycotoxin Res       Date:  2010-02-06       Impact factor: 3.833

Review 4.  Ochratoxin A and human health risk: a review of the evidence.

Authors:  Travis R Bui-Klimke; Felicia Wu
Journal:  Crit Rev Food Sci Nutr       Date:  2015       Impact factor: 11.176

Review 5.  Ochratoxin a in Portugal: a review to assess human exposure.

Authors:  Sofia C Duarte; Angelina Pena; Celeste M Lino
Journal:  Toxins (Basel)       Date:  2010-06-01       Impact factor: 4.546

Review 6.  Ochratoxin A: 50 Years of Research.

Authors:  Frantisek Malir; Vladimir Ostry; Annie Pfohl-Leszkowicz; Jan Malir; Jakub Toman
Journal:  Toxins (Basel)       Date:  2016-07-04       Impact factor: 4.546

Review 7.  Studies on the Presence of Mycotoxins in Biological Samples: An Overview.

Authors:  Laura Escrivá; Guillermina Font; Lara Manyes; Houda Berrada
Journal:  Toxins (Basel)       Date:  2017-08-18       Impact factor: 4.546

Review 8.  An overview of conventional and emerging analytical methods for the determination of mycotoxins.

Authors:  Irena Kralj Cigić; Helena Prosen
Journal:  Int J Mol Sci       Date:  2009-01-02       Impact factor: 6.208

9.  Assessment of multi-mycotoxin exposure in southern Italy by urinary multi-biomarker determination.

Authors:  Michele Solfrizzo; Lucia Gambacorta; Angelo Visconti
Journal:  Toxins (Basel)       Date:  2014-01-28       Impact factor: 4.546

10.  Label-Free G-Quadruplex Aptamer Fluorescence Assay for Ochratoxin A Using a Thioflavin T Probe.

Authors:  Kefeng Wu; Changbei Ma; Han Zhao; Hailun He; Hanchun Chen
Journal:  Toxins (Basel)       Date:  2018-05-12       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.